Praxis Precision Medicines I Share Price

NASDAQ: PRAX

Small Cap

$44.05

+2.05

(+4.87%)

as on September 18, 2025 at 1:29 am IST

$₹

Praxis Precision Medicines I Stock Performance

as on September 18, 2025 at 1:29 am IST

Day's Low
Day's High
$41.89
Day's Price Range
$46.05
$44.05
4.90%
Downside
4.54%
Upside
52 Week's Low
52 Week's High
$26.7
52-Week Price Range
$91.83
$44.05
39.39%
Downside
108.47%
Upside

Praxis Precision Medicines I share price movements today

Previous Close: $42.00
Open: $42.18
Volume: 568.7K
Day's Low - High: $41.89 - $46.05
52 Week Low - High: $26.7 - $91.83

Praxis Precision Medicines I Historical Returns

1 Month Return: -10.79 %
3 Month Return: -3.36 %
1 Year Return: -27.23 %
3 Year Return: + 5.66 %
5 Year Return: 0 %

Praxis Precision Medicines I Stock Fundamentals & Key Indicators

Check Praxis Precision Medicines I market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$851.5M

EPS (TTM)

-13.3711

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-271.4M

Revenue (TTM)

7.8M

Profit Margin

0.00%

Return On Equity TTM

2056000.00%

Praxis Precision Medicines I vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Praxis Precision Medicines I with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Praxis Precision Medicines I	BUY	$851.5M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Stock Returns calculator for Praxis Precision Medicines I Stock including INR - Dollar returns

The Praxis Precision Medicines I stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Praxis Precision Medicines I investment value today

Current value as on today

₹80,915

Returns

₹19,085

(-19.09%)

Returns from Praxis Precision Medicines I Stock

₹23,683 (-23.68%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Praxis Precision Medicines I Stock

Based on 12 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for Praxis Precision Medicines I. Average target price of $101.31

Praxis Precision Medicines I Share Price Target

Get share price movements and forecasts by analysts on Praxis Precision Medicines I.

What analysts predicted

56.52%UPSIDE

Target Price

$101.31

Current Price

$44.05

Analyzed by

12 Analysts

Target

$101.31

Praxis Precision Medicines I target price $101.31, a slight upside of 56.52% compared to current price of $44.05. According to 12 analysts rating.

Praxis Precision Medicines I Stock's Interest Amongst Investors

Search interest for Praxis Precision Medicines I Stock has decreased by -45% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:-45% versus previous 30 day period

Praxis Precision Medicines I Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	0	0	0	0	0	0	0	7	-	-
Gross Profit	0	0	0	0	0	0	0	7	-	0
Operating Income	-38	-34	-25	-27	-41	-37	-56	-63	-74	-76
EBITDA	-37	-34	-25	-27	-41	-37	-56	-63	-74	-71
Interest Expense	0	-	-	0	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-37	-34	-24	-26	-39	-32	-51	-58	-69	-71
Income Tax Expense	0	0	0	0	0	0	-	-	-69	-
Net Income	-36	-34	-24	-26	-39	-32	-51	-58	-69	-71
Net Profit Margin	-5390.78%	-4393.34%	-5263.25%	-5219.03%	-9177.03%	-9153.22%	-17188.74%	-786.27%	0.00%	0.00%

Praxis Precision Medicines I Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	1	2	8
Gross Profit	0	0	0	-1	-1	2	8
Operating Income	-22	-35	-61	-167	-214	-126	-200
EBITDA	-26	-34	-61	-167	-214	-125	-199
Interest Expense	0	-	0	0	0	-	-
Depreciation	0	0	0	0	0	0	0
Income Before Tax	-26	-35	-61	-167	-214	-123	-182
Income Tax Expense	0	0	0	0	0	0	-
Net Income	-26	-35	-61	-166	-213	-123	-182
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-14554.10%	-5037.88%	-2137.48%

Praxis Precision Medicines I Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-34	-24	-26	-39	-32	-51	-58	-69	-71
Operating Cash Flow	-31	-23	-23	-20	-27	-27	-56	-53	-54
Investing Cash Flow	5	-	0	-91	-195	49	-10	-51	17
Financing Cash Flow	69	0	4	182	216	1	113	54	28
Change in Cash	43	-23	-19	70	-6	23	46	-49	-8

Praxis Precision Medicines I Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-35	-61	-167	-214	-123	-182
Operating Cash Flow	-33	-52	-124	-185	-111	-131
Investing Cash Flow	0	0	-140	96	38	-248
Financing Cash Flow	60	304	107	10	91	514
Change in Cash	26	251	-157	-77	19	134

Global Institutional Holdings in Praxis Precision Medicines I

Funds	Holdings
Cormorant Asset Management, LLC	8.29%
Adage Capital Partners Gp LLC	8.28%
HHG PLC	7.16%
BlackRock Inc	6.73%
Morgan Stanley - Brokerage Accounts	5.77%

See all

Insights on Praxis Precision Medicines I

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, PRAX stock has moved up by 6.5%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.9% return, outperforming this stock by 98.2%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 110.8%

About Praxis Precision Medicines I

praxis precision medicines, inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. its lead product candidates include prax-114, an extrasynaptic-preferring gabaa receptor positive allosteric modulator that is in phase iia clinical trial for the treatment of major depressive disorder and perimenopausal depression; and prax-944, a selective small molecule inhibitor of t-type calcium channels, which is in phase iia clinical trial for the treatment of essential tremor. the company is also developing prax-562, a persistent sodium current blocker that is in phase i clinical trial to treat severe pediatric epilepsy and adult cephalgia; prax-222, an antisense oligonucleotide for patients with gain-of-function (gof) scn2a epilepsy; and kcnt1 program for the treatment of kcnt1 gof epilepsy. it has a cooperation and license agreement with rogcon inc.; a license agreement purdue neuroscience company; and a res

Organisation	Praxis Precision Medicines I
Headquarters	99 High Street, Boston, MA, United States, 02110
Industry	Health Technology
CEO	Mr. Marcio Silva De'Souza M.B.A.
E-voting on shares	Click here to vote

Key Management of Praxis Precision Medicines I

Name	Title
Ms. Kelly McCue	Chief People Officer
Dr. Steven Petrou B.Sc. (Hons.), Ph.D.	Co-Founder & Chief Scientific Officer
Lauren Mastrocola	VP of Finance & Principal Accounting Officer
Dr. Karl Hansen Ph.D.	Chief Technical Operations Officer
Mr. Alex Kane	VP of Investor Relations & Corporate Communications
Ms. Alyssa J. S. Wyant	Chief Regulatory & Quality Officer
Ms. Megan T. Sniecinski	Chief Business Officer
Mr. Marcio Silva De'Souza M.B.A.	President, CEO & Director
Mr. Timothy Edwin Kelly	CFO & Treasurer
Mr. Alex Nemiroff J.D.	General Counsel & Secretary

FAQs

What is Praxis Precision Medicines I share price today?

Praxis Precision Medicines I share price today is $44.05 as on September 18, 2025 at 1:29 am IST at the close of the market. Praxis Precision Medicines I share today touched a day high of $46.05 and a low of $41.89.

What is the 52 week high and 52 week low for Praxis Precision Medicines I share?

Praxis Precision Medicines I share touched a 52 week high of $91.83 on February 14, 2025 and a 52 week low of $26.7 on April 9, 2025. Praxis Precision Medicines I stock price today i.e. September 18, 2025 at 1:29 am IST is closed at $44.05,which is 52.03% down from its 52 week high and 64.98% up from its 52 week low.

What is Praxis Precision Medicines I's market capitalisation today?

Praxis Precision Medicines I market capitalisation is $0.00T as on September 18, 2025 at 1:29 am IST.

How to invest in Praxis Precision Medicines I Stock (PRAX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Praxis Precision Medicines I on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Praxis Precision Medicines I Shares that will get you 0.0341 shares as per Praxis Precision Medicines I share price of $44.05 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Praxis Precision Medicines I Stock (PRAX) from India?

Indian investors can start investing in Praxis Precision Medicines I (PRAX) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 8:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Praxis Precision Medicines I stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 8:39 am IST). Based on Praxis Precision Medicines I share’s latest price of $44.05 as on September 18, 2025 at 1:29 am IST, you will get 0.2270 shares of Praxis Precision Medicines I. Learn more about fractional shares .